SMAD4 and colorectal carcinoma: To confirm the association between the SMAD4‐modulated gene profile and DFS in stage II and III patients, we generated a centroid prediction model based on the SMAD4 profile and then investigated its predictive accuracy in a validation dataset of stage II and III CRC patients (n = 257; Table S6).